Literature DB >> 3028461

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.

H F van den Ingh, D J Ruiter, G Griffioen, G N van Muijen, S Ferrone.   

Abstract

Expression of HLA antigens and beta 2-microglobulin was studied by immunoperoxidase staining of frozen sections of 9 mucinous and 10 nonmucinous colorectal adenocarcinomas, 1 cloacogenic carcinoma, 12 colorectal adenomas and 4 samples of normal colorectal mucosa using monoclonal antibodies (MAbs). Staining results were related to histopathological features. HLA Class I antigens were strongly expressed in morphologically normal colorectal epithelium, in all adenomas tested and in all non-mucinous carcinomas. In contrast, expression of HLA class I antigens by the majority of tumour cells was present in only 2 of the 9 mucinous carcinomas, whereas 2 of these mucinous carcinomas were completely negative. In the mucinous carcinomas a striking scarcity of mononuclear inflammatory infiltrate, especially around the mucus accumulations, was observed. HLA class II antigen expression was not detected in normal epithelium and was only focally present in 1 of the 12 adenomas. In 6 out of the 20 carcinomas tested between 20% and 90% of the tumour cells were stained by MAbs against HLA class II antigens. Apart from the low expression of HLA class I antigens in mucinous carcinomas no relationship was found between expression of HLA antigens and histological features of the tumours. The relative poor prognosis of mucinous colorectal carcinoma as reported in the literature may be associated with low expression of HLA class I antigens and scant mononuclear inflammatory infiltrate, which may be a reflection of a weak immune response to the tumour cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3028461      PMCID: PMC2002091          DOI: 10.1038/bjc.1987.26

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  40 in total

1.  Heterogeneous distribution of the determinants defined by monoclonal antibodies on HLA-A and B antigens bearing molecules.

Authors:  M A Pellegrino; A K Ng; C Russo; S Ferrone
Journal:  Transplantation       Date:  1982-07       Impact factor: 4.939

2.  Anomolous expression of HLA-DR antigens on human colorectal cancer cells.

Authors:  A S Daar; S V Fuggle; A Ting; J W Fabre
Journal:  J Immunol       Date:  1982-08       Impact factor: 5.422

3.  Involvement of HLA in T-cell immune responses.

Authors:  E Thorsby; B Bergholtz; E Berle; L Braathen; H Hirschberg
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

Review 4.  HLA restriction of human cytotoxic T cells.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1980-05

5.  Heterogeneity of beta 2-microglobulin in human breast carcinoma.

Authors:  M A Weiss; J G Michael; A J Pesce; L DiPersio
Journal:  Lab Invest       Date:  1981-07       Impact factor: 5.662

6.  Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.

Authors:  D J Ruiter; A K Bhan; T J Harrist; A J Sober; M C Mihm
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

7.  Heterogeneity in the expression of HLA and tumor-associated antigens by surgically removed and cultured breast carcinoma cells.

Authors:  P G Natali; P Giacomini; A Bigotti; K Imai; M R Nicotra; A K Ng; S Ferrone
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

Authors:  K A Fleming; A McMichael; J A Morton; J Woods; J O McGee
Journal:  J Clin Pathol       Date:  1981-07       Impact factor: 3.411

9.  Prognostic significance of histologic host response in cancer of the large bowel.

Authors:  L Nacopoulou; P Azaris; N Papacharalampous; P Davaris
Journal:  Cancer       Date:  1981-03-01       Impact factor: 6.860

10.  Analysis of human tumor cells for Ia-like antigens with monoclonal antibodies.

Authors:  A J Howe; R C Seeger; G A Molinaro; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-05       Impact factor: 13.506

View more
  16 in total

1.  Colonic lymphoid cell subsets and epithelial HLA-DR antigens in familial polyposis coli.

Authors:  Y Horie; M Chiba; M Iizuka; K Igarashi; O Masamune
Journal:  Gastroenterol Jpn       Date:  1989-12

2.  Sporadic loss of leucocyte-function-associated antigen-3 (LFA-3) in colorectal carcinomas.

Authors:  K Koretz; P Schlag; P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 3.  The bodies fight against cancer: is human leucocyte antigen (HLA) class 1 the key?

Authors:  Arfon G M T Powell; Paul G Horgan; Joanne Edwards
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-18       Impact factor: 4.553

4.  Correlation between classification of human urothelial cell lines and HLA-A,B,C expression.

Authors:  S S Ottesen; V Tromholt; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Class II (HLA-DR, -DP, and -DO) antigens on intestinal epithelia in ulcerative colitis, Crohn's disease, colorectal cancer and normal small intestine.

Authors:  Y Horie; M Chiba; M Iizuka; O Masamune
Journal:  Gastroenterol Jpn       Date:  1990-10

6.  Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

Authors:  P G Natali; M R Nicotra; A Bigotti; I Venturo; L Marcenaro; P Giacomini; C Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

7.  HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer.

Authors:  A Ghaderi; A Talei; B Gharesi-Fard; S H Farjadian; A Amirzargar; M Vasei
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.

Authors:  L Kaklamanis; A Townsend; I A Doussis-Anagnostopoulou; N Mortensen; A L Harris; K C Gatter
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

9.  Reduction or loss of HLA-A,B,C antigens in colorectal carcinoma appears not to influence survival.

Authors:  B Stein; F Momburg; V Schwarz; P Schlag; G Moldenhauer; P Möller
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

10.  HLA expression in human hepatocellular carcinoma.

Authors:  A C Paterson; R Sciot; M C Kew; F Callea; G M Dusheiko; V J Desmet
Journal:  Br J Cancer       Date:  1988-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.